Victory Capital Management’s PAVmed PAVM Stock Holding History

Victory Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24	Closed	-$3.25K	–	2613
2023 Q3	$3.25K	Buy	24 +1	+4%	+$155	﹤0.01%	2510
2023 Q2	$4.15K	Buy	+23	New	+$4.6K	﹤0.01%	2505
2022 Q3	–	Sell	-26	Closed	-$11K	–	2755
2022 Q2	$11K	Buy	26 +1	+4%	+$483	﹤0.01%	2646
2022 Q1	$14K	Sell	25 -2	-7%	-$1.49K	﹤0.01%	2656
2021 Q4	$30K	Buy	27 +2	+8%	+$4.35K	﹤0.01%	2668
2021 Q3	$98K	Sell	25 -3	-11%	-$9.46K	﹤0.01%	2621
2021 Q2	$80K	Hold	28	–	–	﹤0.01%	2626
2021 Q1	$56K	Buy	+28	New	+$42.1K	﹤0.01%	2660
2020 Q2	–	Sell	-23	Closed	-$20K	–	3045
2020 Q1	$20K	Buy	+23	New	+$18.8K	﹤0.01%	3098
2019 Q4	–	Sell	-10	Closed	-$4K	–	3074
2019 Q3	$4K	Buy	+10	New	+$4.57K	﹤0.01%	3512

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Victory Capital Management's PAVM Position: Q4 2023 in Review

Victory Capital Management sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 24 shares — an estimated $3.25K sold.

Victory Capital Management first reported a position in PAVM in Q3 2019 and held it in 10 quarters. The position peaked at $98K in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

Victory Capital Management reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
Victory Capital Management sold 24 PAVmed shares in Q4 2023, an estimated $3.25K.
Victory Capital Management first reported a position in PAVmed in Q3 2019 and held it in 10 quarters.
Victory Capital Management's PAVmed position peaked at $98K in Q3 2021.
23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.